Key facts
- Dragon Vascular’s last known valuation is $36.0M (Nov 2025).
- It has raised $18.9M across 1 recorded rounds; the latest was Early Stage VC ($18.9M) in Oct 2025.
- Notable investors include Seraph Group, ND Capital.
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Dragon Vascular
Funding rounds
1 roundsAbout Dragon Vascular
Developer of a medical device technology designed to improve the treatment of neurovascular and vascular disorders. The company offers advanced minimally invasive devices and precision delivery systems, enabling physicians to perform safer and more effective interventions for patients with complex vascular conditions.
- Sector
- Business Products and Services (B2B)
- HQ
- Fremont, CA, United States
- Founded
- 2024
- Employees
- 17
- Website
- dragonvascular.com/
- Ownership
- Privately Held (backing)
Dragon Vascular doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dragon Vascular shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dragon Vascular in its N-PORT filings yet. We sweep new filings monthly.